I, too, am surprised that we haven't gotten any news this week (so far).

I fired off this email to Janet Woodcock yesterday -

Hi Janet,

What's the delay in granting leronlimab EUA? I had read that the FDA wanted to see the unblinded data as soon as possible. Isn't that enough? You should know by now that LL is the best therapeutic to treat severe to critical COVID patients. I hope that Big Pharma is not trying to quash approval for leronlimab because it would hurt their profits. People are dying needlessly.

Thank you,
my name

I haven't received a response and don't expect to because things are at a sensitive stage.

I also just fired off this email to Scott and Nader -

The vast majority of shareholders are totally surprised that we have had no news this week despite management saying that we might have gotten news even last week. Have you decided not to release the unblinded data? Has the topline report not been finalized? Are you waiting for the FDA to make a decision?

Any feedback would be appreciated. Perhaps you should do a brief Proactive interview today to tell shareholders where things stand.

Thanks,
my name

I'll let everyone know if I receive a response.